Anders Michael, Turner Lori, Wallace Lorraine Silver
College of Health Related Professions, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
J Am Acad Nurse Pract. 2007 Jun;19(6):299-305. doi: 10.1111/j.1745-7599.2007.00229.x.
To describe the current literature regarding the benefits of bone mineral density (BMD) screening and to discuss clinical decision rules for BMD screening.
Extensive review of the scientific literature regarding osteoporosis, BMD screening, and current clinical decision rules.
Osteoporosis is a disease characterized by deterioration of bone and increased susceptibility to fractures, crippling, and disfigurement. BMD testing is the best predictor for osteoporosis and associated fractures; however, routine global BMD testing is cost-prohibitive. A need exists for a selective and practical clinical decision rule for referral for testing.
Several effective clinical decision rules are presented, and their uses and applications are described. The osteoporosis self-assessment tool is recommended by the authors because of its predictive power and ease of use.
描述当前有关骨密度（BMD）筛查益处的文献，并讨论BMD筛查的临床决策规则。
对有关骨质疏松症、BMD筛查及当前临床决策规则的科学文献进行广泛综述。
骨质疏松症是一种以骨质恶化、骨折、致残及毁容易感性增加为特征的疾病。BMD检测是骨质疏松症及相关骨折的最佳预测指标；然而，常规的全面BMD检测成本过高。需要一种用于转诊检测的选择性且实用的临床决策规则。
介绍了几种有效的临床决策规则，并描述了其用途和应用。作者推荐骨质疏松症自我评估工具，因其具有预测能力且易于使用。
